レスベラトロール (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "レスベラトロール" in Japanese language version.

refsWebsite

Global rank Japanese rank

63nih.gov

4^th place

24^th place

51doi.org

2^nd place

6^th place

8web.archive.org

1^st place

7harvard.edu

18^th place

107^th place

4wikipedia.org

low place

3worldcat.org

5^th place

19^th place

2nature.com

234^th place

363^rd place

1oregonstate.edu

2,041^st place

4,553^rd place

1phenol-explorer.eu

low place

1kenko-media.com

low place

1wired.com

193^rd place

739^th place

1okajima-lab.net

low place

1kanazawa-med.ac.jp

low place

1medlineplus.gov

1,581^st place

9,554^th place

1cell.com

2,814^th place

4,178^th place

1nytimes.com

7^th place

63^rd place

1oup.com

485^th place

1,439^th place

1handle.net

102^nd place

78^th place

1proquest.com

206^th place

3,819^th place

1wikidata.org

43^rd place

1,892^nd place

1springer.com

274^th place

596^th place

1mhlw.go.jp

1,656^th place

110^th place

1cyclex.co.jp

low place

1kansai-u.ac.jp

low place

984^th place

1mendeley.com

low place

1boston.com

310^th place

1,275^th place

1cnn.com

28^th place

188^th place

1businessweek.com

712^th place

2,076^th place

1fiercebiotech.com

low place

boston.com

Rimas A (2006年12月11日). “His research targets the aging process”. The Boston Globe

businessweek.com

Weintraub A (2009年7月29日). “Resveratrol: The Hard Sell on Anti-Aging”. Bloomberg Businessweek. オリジナルのJuly 31, 2009時点におけるアーカイブ。

cell.com

Timmers S. et al. Cell Metabolism 14(5):612-622 (2011) [1]

cnn.com

money.cnn.com

Stipp D (2007年1月19日). “Can red wine help you live forever?”. フォーチュン誌

cyclex.co.jp

CycLex Web Site Archived 2012年12月15日, at the Wayback Machine.

doi.org

Fremont, Lucie (January 2000). “Biological Effects of Resveratrol”. Life Sciences 66 (8): 663–673. doi:10.1016/S0024-3205(99)00410-5. PMID 10680575.
“Resveratrol in prostate diseases – a short review”. Central European Journal of Urology 66 (2): 144–149. (August 2013). doi:10.5173/ceju.2013.02.art8. PMC 3936154. PMID 24579014.
Joseph A. Baur, et al. (2006). “Resveratrol improves health and survival of mice on a high-calorie diet”. Nature 444 (7117): 337–342. doi:10.1038/nature05354. PMID 17086191.
“What is new for an old molecule? Systematic review and recommendations on the use of resveratrol”. PLOS ONE 6 (6): e19881. (2011). Bibcode: 2011PLoSO...619881V. doi:10.1371/journal.pone.0019881. PMC 3116821. PMID 21698226.
“Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors – Results from a systematic review and meta-analysis of randomized controlled trials”. International Journal of Cardiology 189: 47–55. (2015). doi:10.1016/j.ijcard.2015.04.008. PMID 25885871.
“Health benefits of resveratrol: Evidence from clinical studies”. Med Res Rev 39 (5): 1851–1891. (September 2019). doi:10.1002/med.21565. PMID 30741437.
Zeraattalab-Motlagh, S; Jayedi, A; Shab-Bidar, S (8 November 2021). “The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials”. The American Journal of Clinical Nutrition 114 (5): 1675–1685. doi:10.1093/ajcn/nqab250. PMID 34320173.
“Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective”. Annals of the New York Academy of Sciences 1290 (1): 37–51. (Jul 2013). Bibcode: 2013NYASA1290...37T. doi:10.1111/nyas.12150. PMID 23855464.
“Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials”. Critical Reviews in Food Science and Nutrition 58 (2): 1605–1618. (January 2018). doi:10.1080/10408398.2017.1422480. PMID 29359958.
“Effect of resveratrol on blood pressure: A meta-analysis of randomized controlled trials”. Clinical Nutrition 34 (1): 27–34. (March 2014). doi:10.1016/j.clnu.2014.03.009. PMID 24731650.
“Resveratrol and cancer: focus on in vivo evidence”. Endocr. Relat. Cancer 21 (3): R209–R225. (June 2014). doi:10.1530/ERC-13-0171. PMC 4013237. PMID 24500760.
“Resveratrol in metabolic health: an overview of the current evidence and perspectives”. Annals of the New York Academy of Sciences 1290 (1): 74–82. (Jul 2013). Bibcode: 2013NYASA1290...74P. doi:10.1111/nyas.12141. PMID 23855468.
“Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus-systematic review and meta-analysis”. Molecular Nutrition & Food Research 59 (1): 147–159. (19 August 2014). doi:10.1002/mnfr.201400173. PMID 25138371.
De Ligt, M; Timmers, S; Schrauwen, P (2015). “Resveratrol and obesity: Can resveratrol relieve metabolic disturbances?”. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1852 (6): 1137–1144. doi:10.1016/j.bbadis.2014.11.012. PMID 25446988.
“Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus – systematic review and meta-analysis”. Mol Nutr Food Res 59 (1): 147–159. (2015). doi:10.1002/mnfr.201400173. PMID 25138371.
Zhu, Xiangyun; Wu, Chunhua; Qiu, Shanhu; Yuan, Xuelu; Li, Ling (22 September 2017). “Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis” (英語). Nutrition & Metabolism 14 (1): 60. doi:10.1186/s12986-017-0217-z. ISSN 1743-7075. PMC 5610395. PMID 29018489.
Mousavi, S. M.; Milajerdi, A.; Sheikhi, A.; Kord-Varkaneh, H.; Feinle-Bisset, C.; Larijani, B.; Esmaillzadeh, A. (2019). “Resveratrol supplementation significantly influences obesity measures: a systematic review and dose–response meta-analysis of randomized controlled trials”. Obesity Reviews 20 (3): 487–498. doi:10.1111/obr.12775. PMID 30515938.
Asgary, Sedigheh; Karimi, Raheleh; Momtaz, Saeideh; Naseri, Rozita; Farzaei, Mohammad Hosein (1 June 2019). “Effect of resveratrol on metabolic syndrome components: A systematic review and meta-analysis”. Reviews in Endocrine and Metabolic Disorders 20 (2): 173–186. doi:10.1007/s11154-019-09494-z. PMID 31065943.
Koushki, Mehdi; Dashatan, Nasrin Amiri; Meshkani, Reza (July 2018). “Effect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials”. Clinical Therapeutics 40 (7): 1180–1192.e5. doi:10.1016/j.clinthera.2018.05.015. PMID 30017172.
Marx, Wolfgang; Kelly, Jaimon T.; Marshall, Skye; Cutajar, Jennifer; Annois, Brigitte; Pipingas, Andrew; Tierney, Audrey; Itsiopoulos, Catherine (1 June 2018). “Effect of resveratrol supplementation on cognitive performance and mood in adults: a systematic literature review and meta-analysis of randomized controlled trials”. Nutrition Reviews 76 (6): 432–443. doi:10.1093/nutrit/nuy010. hdl:10072/389251. PMID 29596658.
“Effects of Resveratrol Supplementation on the Cognitive Function of Patients with Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials”. Drugs & Aging 39 (4): 285–295. (April 2022). doi:10.1007/s40266-022-00923-4. PMID 35187615.
“Resveratrol for adults with type 2 diabetes mellitus”. Cochrane Database Syst Rev 1 (1): CD011919. (January 2020). doi:10.1002/14651858.CD011919.pub2. PMC 6984411. PMID 31978258.
Asis, Marzieh; Hemmati, Niloufar; Moradi, Sajjad et al. (December 2019). “Effects of resveratrol supplementation on bone biomarkers: a systematic review and meta-analysis”. Annals of the New York Academy of Sciences 1457 (1): 92–103. Bibcode: 2019NYASA1457...92A. doi:10.1111/nyas.14226. PMID 31490554.
Baell, J; Walters, MA (25 September 2014). “Chemistry: Chemical con artists foil drug discovery”. Nature 513 (7519): 481–483. Bibcode: 2014Natur.513..481B. doi:10.1038/513481a. PMID 25254460.
Ingólfsson, HI; Thakur, P; Herold, KF et al. (15 August 2014). “Phytochemicals perturb membranes and promiscuously alter protein function”. ACS Chemical Biology 9 (8): 1788–1798. doi:10.1021/cb500086e. PMC 4136704. PMID 24901212.
Vang, O (August 2015). “Resveratrol: challenges in analyzing its biological effects”. Annals of the New York Academy of Sciences 1348 (1): 161–170. Bibcode: 2015NYASA1348..161V. doi:10.1111/nyas.12879. PMID 26315294.
“High absorption but very low bioavailability of oral resveratrol in humans”. Drug Metab. Dispos. 32 (12): 1377–1382. (December 2004). doi:10.1124/dmd.104.000885. PMID 15333514.
“Bioactivity of dietary polyphenols: The role of metabolites”. 食品科学栄養学批評（英語版） 60 (4): 626–659. (2020). doi:10.1080/10408398.2018.1546669. PMID 30614249.
“Therapeutic potential of resveratrol: the in vivo evidence”. ネイチャー・レビュー・ドラッグ・ディスカバリー（英語版） 5 (6): 493–506. (2006). doi:10.1038/nrd2060. PMID 16732220.
Sharan S, Nagar S; Nagar (2013). “Pulmonary metabolism of resveratrol: In vitro and in vivo evidence”. Drug Metabolism and Disposition 41 (5): 1163–1169. doi:10.1124/dmd.113.051326. PMC 3629805. PMID 23474649.
“Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol”. 国際分子科学ジャーナル（英語版） 20 (6): 1381. (2019). doi:10.3390/ijms20061381. PMC 6471659. PMID 30893846.
“Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans”. 酸化医学と細胞寿命 2015: 837042. (2015). doi:10.1155/2015/837042. PMC 4499410. PMID 26221416.
“Isolation, characterization, and evolution in red wine vinification of resveratrol monomers”. Journal of Agricultural and Food Chemistry 43 (7): 1820–1823. (1995). doi:10.1021/jf00055a013.
“Direct HPLC Analysis of cis- and trans-Resveratrol and Piceid Isomers in Spanish Red Vitis vinifera Wines”. Journal of Agricultural and Food Chemistry 43 (2): 281–283. (1995). doi:10.1021/jf00050a003.
“Photochemical generation of a new, highly fluorescent compound from non-fluorescent resveratrol”. Chemical Communications 48 (32): 3839–3841. (2012). doi:10.1039/C2CC30940H. PMID 22436889.
“Resveratrol and its glycon piceid are stable polyphenols”. J Med Food 9 (1): 11–14. (2006). doi:10.1089/jmf.2006.9.11. PMID 16579722.
“Stability of trans-resveratrol associated with transport proteins”. J Agric Food Chem 62 (19): 4384–4391. (2014). doi:10.1021/jf405584a. PMID 24773207.
Valletta, Alessio; Iozia, Lorenzo Maria; Leonelli, Francesca (January 2021). “Impact of Environmental Factors on Stilbene Biosynthesis” (英語). Plants 10 (1): 90. doi:10.3390/plants10010090. PMC 7823792. PMID 33406721.
Dubrovina, A. S.; Kiselev, K. V. (October 2017). “Regulation of stilbene biosynthesis in plants” (英語). Planta 246 (4): 597–623. Bibcode: 2017Plant.246..597D. doi:10.1007/s00425-017-2730-8. ISSN 0032-0935. PMID 28685295.
Wang, Chuanhong; Zhi, Shuang; Liu, Changying et al. (2017). “Characterization of Stilbene Synthase Genes in Mulberry (Morus atropurpurea) and Metabolic Engineering for the Production of Resveratrol in Escherichia coli”. Journal of Agricultural and Food Chemistry 65 (8): 1659–1668. doi:10.1021/acs.jafc.6b05212. PMID 28168876.
“Dimerization of resveratrol by the grapevine pathogen Botrytis cinerea”. J. Nat. Prod. 63 (1): 29–33. (January 2000). doi:10.1021/np990266n. PMID 10650073.
Cichewicz RH, Kouzi SA; Kouzi (October 1998). “Biotransformation of resveratrol to piceid by Bacillus cereus”. J. Nat. Prod. 61 (10): 1313–1314. doi:10.1021/np980139b. PMID 9784180.
“Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans”. 分子栄養食品研究（英語版） 58 (1): 7–21. (2014). doi:10.1002/mnfr.201200589. PMID 23740855.
Sales, JM; Resurreccion, AV (2014). “Resveratrol in peanuts”. Critical Reviews in Food Science and Nutrition 54 (6): 734–770. doi:10.1080/10408398.2011.606928. PMID 24345046.
“A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine”. Food Chemistry 101 (2): 449–457. (2007). doi:10.1016/j.foodchem.2006.01.047.
Naiker, M.; Anderson, S.; Johnson, J. B.; Mani, J. S.; Wakeling, L.; Bowry, V. (2020-07-21). “Loss of trans -resveratrol during storage and ageing of red wines” (英語). Australian Journal of Grape and Wine Research 26 (4): 385–387. doi:10.1111/ajgw.12449. ISSN 1322-7130.
“Resveratrol: a candidate nutritional substance for prostate cancer prevention”. J. Nutr. 133 (7 Suppl): 2440S–2443S. (July 2003). doi:10.1093/jn/133.7.2440S. PMID 12840221.
Takaoka M (1939). “Resveratrol, a new phenolic compound, from Veratrum grandiflorum”. Journal of the Chemical Society of Japan 60 (11): 1090–1100. doi:10.1246/nikkashi1921.60.1090.
Takaoka, Michio (1940). “The Phenolic Substances of White Hellebore (Veratrum Grandiflorum Loes. Fill). V”. Nippon Kagaku Kaishi 61 (10): 1067–1069. doi:10.1246/nikkashi1921.61.1067.
Nonomura; Kanagawa (1963). “Chemical constituents of Polygonaceous plants. I. studies on the components of Ko-jo-kon. (Polygonum cuspidatum SIEB et ZUCC)”. Yakugaku Zasshi 83 (10): 988–990. doi:10.1248/yakushi1947.83.10_988.
“Biotransformation of mulberroside A from Morus alba results in enhancement of tyrosinase inhibition”. J. Ind. Microbiol. Biotechnol. 37 (6): 631–637. (June 2010). doi:10.1007/s10295-010-0722-9. PMID 20411402.

fiercebiotech.com

Carroll, John; McBride, Ryan (Mar 12, 2013). “Updated: GSK moves to shutter Sirtris' Cambridge office, integrate R&D” (英語). FierceBiotech. オリジナルのApril 28, 2019時点におけるアーカイブ。 August 17, 2017閲覧。

handle.net

hdl.handle.net

Marx, Wolfgang; Kelly, Jaimon T.; Marshall, Skye; Cutajar, Jennifer; Annois, Brigitte; Pipingas, Andrew; Tierney, Audrey; Itsiopoulos, Catherine (1 June 2018). “Effect of resveratrol supplementation on cognitive performance and mood in adults: a systematic literature review and meta-analysis of randomized controlled trials”. Nutrition Reviews 76 (6): 432–443. doi:10.1093/nutrit/nuy010. hdl:10072/389251. PMID 29596658.

harvard.edu

ui.adsabs.harvard.edu

“What is new for an old molecule? Systematic review and recommendations on the use of resveratrol”. PLOS ONE 6 (6): e19881. (2011). Bibcode: 2011PLoSO...619881V. doi:10.1371/journal.pone.0019881. PMC 3116821. PMID 21698226.
“Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective”. Annals of the New York Academy of Sciences 1290 (1): 37–51. (Jul 2013). Bibcode: 2013NYASA1290...37T. doi:10.1111/nyas.12150. PMID 23855464.
“Resveratrol in metabolic health: an overview of the current evidence and perspectives”. Annals of the New York Academy of Sciences 1290 (1): 74–82. (Jul 2013). Bibcode: 2013NYASA1290...74P. doi:10.1111/nyas.12141. PMID 23855468.
Asis, Marzieh; Hemmati, Niloufar; Moradi, Sajjad et al. (December 2019). “Effects of resveratrol supplementation on bone biomarkers: a systematic review and meta-analysis”. Annals of the New York Academy of Sciences 1457 (1): 92–103. Bibcode: 2019NYASA1457...92A. doi:10.1111/nyas.14226. PMID 31490554.
Baell, J; Walters, MA (25 September 2014). “Chemistry: Chemical con artists foil drug discovery”. Nature 513 (7519): 481–483. Bibcode: 2014Natur.513..481B. doi:10.1038/513481a. PMID 25254460.
Vang, O (August 2015). “Resveratrol: challenges in analyzing its biological effects”. Annals of the New York Academy of Sciences 1348 (1): 161–170. Bibcode: 2015NYASA1348..161V. doi:10.1111/nyas.12879. PMID 26315294.
Dubrovina, A. S.; Kiselev, K. V. (October 2017). “Regulation of stilbene biosynthesis in plants” (英語). Planta 246 (4): 597–623. Bibcode: 2017Plant.246..597D. doi:10.1007/s00425-017-2730-8. ISSN 0032-0935. PMID 28685295.

kanazawa-med.ac.jp

“インスリン抵抗性に対する新たな治療手段”. 金沢医科大学糖尿病・内分泌内科学. 2013年6月1日時点のオリジナルよりアーカイブ。2011年6月14日閲覧。

kansai-u.ac.jp

pharm.life-bio.kansai-u.ac.jp

ヒストン脱アセチル化酵素（HDAC）阻害物質の分子設計とその抗がん剤への応用（研究概要） Archived 2012年7月20日, at the Wayback Machine.

kenko-media.com

“ブドウ由来素材、レスベラトロールに注目集まる（発行日: 2009/4/3）”. 健康産業新聞. 2011年11月16日時点のオリジナルよりアーカイブ。2011年5月30日閲覧。

medlineplus.gov

“Resveratrol”. MedlinePlus (1 April 2019). 22 September 2019閲覧。

mendeley.com

Takaoka M (1939). “Resveratrol, a new phenolic compound, from Veratrum grandiflorum”. Journal of the Chemical Society of Japan 60 (11): 1090–1100. doi:10.1246/nikkashi1921.60.1090.

mhlw.go.jp

第二類医薬品 (PDF) （平成30.7.8最終改正）（厚生労働省ホームページ医薬品の販売制度｜厚生労働省より）（第二類医薬品において「コジョウコン」の記述）

nature.com

Joseph A. Baur, et al. (2006). “Resveratrol improves health and survival of mice on a high-calorie diet”. Nature 444 (7117): 337–342. doi:10.1038/nature05354. PMID 17086191.

blogs.nature.com

“GSK absorbs controversial 'longevity' company: News blog”. Nature Blog. 2013年12月17日時点のオリジナルよりアーカイブ。2017年8月17日閲覧。.

nih.gov

pubmed.ncbi.nlm.nih.gov

Fremont, Lucie (January 2000). “Biological Effects of Resveratrol”. Life Sciences 66 (8): 663–673. doi:10.1016/S0024-3205(99)00410-5. PMID 10680575.
“Resveratrol in prostate diseases – a short review”. Central European Journal of Urology 66 (2): 144–149. (August 2013). doi:10.5173/ceju.2013.02.art8. PMC 3936154. PMID 24579014.
Bhat KPL, et al. Antioxid Redox Signal, 3(6):1041-64. (2001) PMID 11813979.
Howitz KT, et al. Nature, 425(6954):191-6. (2003) PMID 12939617.
Viswanathan M, et al. Dev Cell, 9(5):605-15. (2005) PMID 16256736.
Bauer JH, et al. Proc Natl Acad Sci USA, 101(35):12980-5. (2004) PMID 15328413.
Valenzano DR, et al. Curr Biol, 16(3):296-300. (2006) PMID 16461283.
Joseph A. Baur, et al. (2006). “Resveratrol improves health and survival of mice on a high-calorie diet”. Nature 444 (7117): 337–342. doi:10.1038/nature05354. PMID 17086191.
Lagouge M, et al. Cell, 127, 1109-1122, (2006) PMID 17112576.
“What is new for an old molecule? Systematic review and recommendations on the use of resveratrol”. PLOS ONE 6 (6): e19881. (2011). Bibcode: 2011PLoSO...619881V. doi:10.1371/journal.pone.0019881. PMC 3116821. PMID 21698226.
“Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors – Results from a systematic review and meta-analysis of randomized controlled trials”. International Journal of Cardiology 189: 47–55. (2015). doi:10.1016/j.ijcard.2015.04.008. PMID 25885871.
“Health benefits of resveratrol: Evidence from clinical studies”. Med Res Rev 39 (5): 1851–1891. (September 2019). doi:10.1002/med.21565. PMID 30741437.
Zeraattalab-Motlagh, S; Jayedi, A; Shab-Bidar, S (8 November 2021). “The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials”. The American Journal of Clinical Nutrition 114 (5): 1675–1685. doi:10.1093/ajcn/nqab250. PMID 34320173.
“Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective”. Annals of the New York Academy of Sciences 1290 (1): 37–51. (Jul 2013). Bibcode: 2013NYASA1290...37T. doi:10.1111/nyas.12150. PMID 23855464.
“Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials”. Critical Reviews in Food Science and Nutrition 58 (2): 1605–1618. (January 2018). doi:10.1080/10408398.2017.1422480. PMID 29359958.
“Effect of resveratrol on blood pressure: A meta-analysis of randomized controlled trials”. Clinical Nutrition 34 (1): 27–34. (March 2014). doi:10.1016/j.clnu.2014.03.009. PMID 24731650.
“Resveratrol and cancer: focus on in vivo evidence”. Endocr. Relat. Cancer 21 (3): R209–R225. (June 2014). doi:10.1530/ERC-13-0171. PMC 4013237. PMID 24500760.
Brown VA, et al. Cancer Res, 70(22):9003-11. (2010) PMID 20935227.
“Resveratrol in metabolic health: an overview of the current evidence and perspectives”. Annals of the New York Academy of Sciences 1290 (1): 74–82. (Jul 2013). Bibcode: 2013NYASA1290...74P. doi:10.1111/nyas.12141. PMID 23855468.
“Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus-systematic review and meta-analysis”. Molecular Nutrition & Food Research 59 (1): 147–159. (19 August 2014). doi:10.1002/mnfr.201400173. PMID 25138371.
De Ligt, M; Timmers, S; Schrauwen, P (2015). “Resveratrol and obesity: Can resveratrol relieve metabolic disturbances?”. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1852 (6): 1137–1144. doi:10.1016/j.bbadis.2014.11.012. PMID 25446988.
“Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus – systematic review and meta-analysis”. Mol Nutr Food Res 59 (1): 147–159. (2015). doi:10.1002/mnfr.201400173. PMID 25138371.
Zhu, Xiangyun; Wu, Chunhua; Qiu, Shanhu; Yuan, Xuelu; Li, Ling (22 September 2017). “Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis” (英語). Nutrition & Metabolism 14 (1): 60. doi:10.1186/s12986-017-0217-z. ISSN 1743-7075. PMC 5610395. PMID 29018489.
Mousavi, S. M.; Milajerdi, A.; Sheikhi, A.; Kord-Varkaneh, H.; Feinle-Bisset, C.; Larijani, B.; Esmaillzadeh, A. (2019). “Resveratrol supplementation significantly influences obesity measures: a systematic review and dose–response meta-analysis of randomized controlled trials”. Obesity Reviews 20 (3): 487–498. doi:10.1111/obr.12775. PMID 30515938.
Asgary, Sedigheh; Karimi, Raheleh; Momtaz, Saeideh; Naseri, Rozita; Farzaei, Mohammad Hosein (1 June 2019). “Effect of resveratrol on metabolic syndrome components: A systematic review and meta-analysis”. Reviews in Endocrine and Metabolic Disorders 20 (2): 173–186. doi:10.1007/s11154-019-09494-z. PMID 31065943.
Koushki, Mehdi; Dashatan, Nasrin Amiri; Meshkani, Reza (July 2018). “Effect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials”. Clinical Therapeutics 40 (7): 1180–1192.e5. doi:10.1016/j.clinthera.2018.05.015. PMID 30017172.
Marx, Wolfgang; Kelly, Jaimon T.; Marshall, Skye; Cutajar, Jennifer; Annois, Brigitte; Pipingas, Andrew; Tierney, Audrey; Itsiopoulos, Catherine (1 June 2018). “Effect of resveratrol supplementation on cognitive performance and mood in adults: a systematic literature review and meta-analysis of randomized controlled trials”. Nutrition Reviews 76 (6): 432–443. doi:10.1093/nutrit/nuy010. hdl:10072/389251. PMID 29596658.
Kennedy DO, et al. Am J Clin Nutr, 91(6), 1590-7. (2010) PMID 20357044.
“Effects of Resveratrol Supplementation on the Cognitive Function of Patients with Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials”. Drugs & Aging 39 (4): 285–295. (April 2022). doi:10.1007/s40266-022-00923-4. PMID 35187615.
“Resveratrol for adults with type 2 diabetes mellitus”. Cochrane Database Syst Rev 1 (1): CD011919. (January 2020). doi:10.1002/14651858.CD011919.pub2. PMC 6984411. PMID 31978258.
Asis, Marzieh; Hemmati, Niloufar; Moradi, Sajjad et al. (December 2019). “Effects of resveratrol supplementation on bone biomarkers: a systematic review and meta-analysis”. Annals of the New York Academy of Sciences 1457 (1): 92–103. Bibcode: 2019NYASA1457...92A. doi:10.1111/nyas.14226. PMID 31490554.
Baell, J; Walters, MA (25 September 2014). “Chemistry: Chemical con artists foil drug discovery”. Nature 513 (7519): 481–483. Bibcode: 2014Natur.513..481B. doi:10.1038/513481a. PMID 25254460.
Ingólfsson, HI; Thakur, P; Herold, KF et al. (15 August 2014). “Phytochemicals perturb membranes and promiscuously alter protein function”. ACS Chemical Biology 9 (8): 1788–1798. doi:10.1021/cb500086e. PMC 4136704. PMID 24901212.
Vang, O (August 2015). “Resveratrol: challenges in analyzing its biological effects”. Annals of the New York Academy of Sciences 1348 (1): 161–170. Bibcode: 2015NYASA1348..161V. doi:10.1111/nyas.12879. PMID 26315294.
“High absorption but very low bioavailability of oral resveratrol in humans”. Drug Metab. Dispos. 32 (12): 1377–1382. (December 2004). doi:10.1124/dmd.104.000885. PMID 15333514.
“Bioactivity of dietary polyphenols: The role of metabolites”. 食品科学栄養学批評（英語版） 60 (4): 626–659. (2020). doi:10.1080/10408398.2018.1546669. PMID 30614249.
“Therapeutic potential of resveratrol: the in vivo evidence”. ネイチャー・レビュー・ドラッグ・ディスカバリー（英語版） 5 (6): 493–506. (2006). doi:10.1038/nrd2060. PMID 16732220.
Sharan S, Nagar S; Nagar (2013). “Pulmonary metabolism of resveratrol: In vitro and in vivo evidence”. Drug Metabolism and Disposition 41 (5): 1163–1169. doi:10.1124/dmd.113.051326. PMC 3629805. PMID 23474649.
“Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol”. 国際分子科学ジャーナル（英語版） 20 (6): 1381. (2019). doi:10.3390/ijms20061381. PMC 6471659. PMID 30893846.
“Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans”. 酸化医学と細胞寿命 2015: 837042. (2015). doi:10.1155/2015/837042. PMC 4499410. PMID 26221416.
“Photochemical generation of a new, highly fluorescent compound from non-fluorescent resveratrol”. Chemical Communications 48 (32): 3839–3841. (2012). doi:10.1039/C2CC30940H. PMID 22436889.
“Resveratrol and its glycon piceid are stable polyphenols”. J Med Food 9 (1): 11–14. (2006). doi:10.1089/jmf.2006.9.11. PMID 16579722.
“Stability of trans-resveratrol associated with transport proteins”. J Agric Food Chem 62 (19): 4384–4391. (2014). doi:10.1021/jf405584a. PMID 24773207.
“Stability of resveratrol over time and in the various stages of grape transformation”. Drugs Exp Clin Res 24 (4): 207–211. (1998). PMID 10051967.
Valletta, Alessio; Iozia, Lorenzo Maria; Leonelli, Francesca (January 2021). “Impact of Environmental Factors on Stilbene Biosynthesis” (英語). Plants 10 (1): 90. doi:10.3390/plants10010090. PMC 7823792. PMID 33406721.
Dubrovina, A. S.; Kiselev, K. V. (October 2017). “Regulation of stilbene biosynthesis in plants” (英語). Planta 246 (4): 597–623. Bibcode: 2017Plant.246..597D. doi:10.1007/s00425-017-2730-8. ISSN 0032-0935. PMID 28685295.
Wang, Chuanhong; Zhi, Shuang; Liu, Changying et al. (2017). “Characterization of Stilbene Synthase Genes in Mulberry (Morus atropurpurea) and Metabolic Engineering for the Production of Resveratrol in Escherichia coli”. Journal of Agricultural and Food Chemistry 65 (8): 1659–1668. doi:10.1021/acs.jafc.6b05212. PMID 28168876.
“Dimerization of resveratrol by the grapevine pathogen Botrytis cinerea”. J. Nat. Prod. 63 (1): 29–33. (January 2000). doi:10.1021/np990266n. PMID 10650073.
Cichewicz RH, Kouzi SA; Kouzi (October 1998). “Biotransformation of resveratrol to piceid by Bacillus cereus”. J. Nat. Prod. 61 (10): 1313–1314. doi:10.1021/np980139b. PMID 9784180.
“Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans”. 分子栄養食品研究（英語版） 58 (1): 7–21. (2014). doi:10.1002/mnfr.201200589. PMID 23740855.
Sales, JM; Resurreccion, AV (2014). “Resveratrol in peanuts”. Critical Reviews in Food Science and Nutrition 54 (6): 734–770. doi:10.1080/10408398.2011.606928. PMID 24345046.
“Resveratrol: a candidate nutritional substance for prostate cancer prevention”. J. Nutr. 133 (7 Suppl): 2440S–2443S. (July 2003). doi:10.1093/jn/133.7.2440S. PMID 12840221.
“Biotransformation of mulberroside A from Morus alba results in enhancement of tyrosinase inhibition”. J. Ind. Microbiol. Biotechnol. 37 (6): 631–637. (June 2010). doi:10.1007/s10295-010-0722-9. PMID 20411402.